Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Trichohyalin may trigger the immune response causing alopecia areata.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Targeting specific cell interactions may help treat skin fibrosis.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.